Fagron N.V.
FAGR | BR
Overview
Corporate Details
- ISIN(s):
- BE0003874915
- LEI:
- 549300TRKRUFK2RRG779
- Country:
- Belgium
- Address:
- Venecoweg 20A, 9810 Nazareth
- Website:
- https://fagron.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Fagron is active in 35 countries in EMEA, North America, and Latin America. Fagron has sterile and non-sterile compounding facilities in Europe (the Netherlands, Belgium, and the Czech Republic), Israel, the United States, Colombia, and South Africa, which supply medications to pharmacies, hospitals, and clinics, as well as directly to patients in South Africa and Colombia. With over 400 pharmacists within Fagron, we are focused on providing a unique range of high-quality products based on scientific data and insights. The Fagron Brands are unique concepts developed by our R&D specialists to provide pharmacies and clients with exclusive pharmaceutical dosage forms and active pharmaceutical ingredients (APIs). We can provide solutions for all steps inside a compounding setting, either equipment, excipients, APIs, packaging, and much more.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-07-31 08:22 |
Inside Information Statement
Fagron delivers strong performance with 11% topline growth and 12% increase in …
|
English | 209.5 KB | |
| 2025-07-31 08:22 |
Inside Information Statement
Fagron delivers strong performance with 11% topline growth and 12% increase in …
|
English | 987.2 KB | |
| 2025-07-31 08:21 |
Inside Information Statement
Fagron levert sterke resultaten met een omzetgroei van 11% en 12% stijging van …
|
English | 205.8 KB | |
| 2025-07-31 08:21 |
Inside Information Statement
Fagron levert sterke resultaten met een omzetgroei van 11% en 12% stijging van …
|
English | 993.4 KB | |
| 2025-07-31 07:00 |
Regulatory News Service
Fagron - IFS 30-07-2025 EN.pdf
|
English | 1.6 MB | |
| 2025-07-31 07:00 |
Regulatory News Service
Fagron - IFS 30-07-2025 NL.pdf
|
Dutch | 1.6 MB | |
| 2025-07-31 07:00 |
Interim Report
Fagron - H1 2025 PR EN.pdf
|
English | 987.2 KB | |
| 2025-07-31 07:00 |
Interim Report
Fagron - H1 2025 PR NL.pdf
|
Dutch | 993.4 KB | |
| 2025-07-21 07:39 |
Declaration of Voting Results & Voting Rights Announcements
Disclosure of notification received from Alychlo
|
Dutch | 479.4 KB | |
| 2025-07-21 07:39 |
Declaration of Voting Results & Voting Rights Announcements
Disclosure of notification received from Alychlo
|
English | 489.9 KB | |
| 2025-07-18 18:00 |
Declaration of Voting Results & Voting Rights Announcements
250718_Fagron transparency Alychlo_PR_ENG.pdf
|
English | 489.9 KB | |
| 2025-07-18 18:00 |
Declaration of Voting Results & Voting Rights Announcements
250718_Fagron transparency Alychlo_PR_NL.pdf
|
Dutch | 479.4 KB | |
| 2025-06-09 08:27 |
Declaration of Voting Results & Voting Rights Announcements
Fagron increases share capital through exercise subscription rights
|
English | 93.1 KB | |
| 2025-06-09 08:27 |
Declaration of Voting Results & Voting Rights Announcements
Fagron increases share capital through exercise subscription rights
|
Dutch | 398.4 KB | |
| 2025-06-06 19:00 |
Declaration of Voting Results & Voting Rights Announcements
250606 - Press release increase share capital 6 June 2025.pdf
|
English | 93.1 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-05-23 | Pulido Andrew | Executive member | Sell | 85,000 | 1,803,351.50 EUR |
| 2025-05-22 | Pulido Andrew | Executive member | Buy | 85,000 | 1,617,550.00 EUR |
| 2025-05-02 | De Jong Cornelia Neeltje | Board | Sell | 12,689 | 263,834.55 EUR |
| 2025-04-30 | De Jong Cornelia Neeltje | Board | Sell | 229 | 4,660.15 EUR |
| 2025-04-29 | De Jong Cornelia Neeltje | Board | Sell | 10,000 | 201,500.00 EUR |
| 2025-03-28 | J. Verlinden | Other | Buy | 24,551 | 453,702.48 EUR |
| 2025-03-28 | J. Verlinden | Other | Sell | 17,930 | 344,047.56 EUR |
| 2025-03-27 | Padilla Rafael | Board | Buy | 78,469 | 1,450,107.12 EUR |
| 2025-03-27 | De Jong Cornelia Neeltje | Board | Buy | 45,418 | 839,324.64 EUR |
| 2025-02-21 | Bakker Vera | Executive member | Buy | 773 | 15,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Cuorips Inc. | Japan | 4894 | |
|
Cyfuse Biomedical K.K. | Japan | 4892 | |
|
DAIICHI SANKYO COMPANY, LIMITED | Japan | 4568 | |
|
Daito Pharmaceutical Co., Ltd. | Japan | 4577 | |
|
DanCann Pharma A/S | Denmark | DANCAN | |
|
DARWIN AG | Germany | 7V0 | |
|
Dechra Pharmaceuticals PLC | United Kingdom | DPH | |
|
Delta-Fly Pharma, Inc. | Japan | 4598 | |
|
Dermapharm Holding SE | Germany | DMP | |
|
Dicot Pharma AB | Sweden | DICOTBT |